Stimuli-sensitive drug carriers can aid in the treatment of diabetes as glucose biosensors and glucose-triggered insulin delivery systems.
A tumor prodrug, which is able to monitor drug release and therapeutic success in real time, is developed.
A new review in Advanced Science summarizes new nanotechnology-based potential diagnosis and treatment methods for triple negative breast cancer.
Interfaces to capture, detect, and analyze circulating tumor cells are reviewed, which give a valuable insight into tumor progression and metastasis.
Rejection or diminished functionability of implants are frequent problems. A new type of coating could limit associated infections and inflammations.
Matthias Barz and Kristina Klinker provide a first overview concerning the work on polypept(o)ides.
Aggregation-induced emission nanoparticles have been developed by East China University researchers for cancer diagnostics and treatment.
A new chemotherapeutic strategy combining MHPMA copolymer-based drug formulations for the treatment of acute myeloid leukemia is presented.
Tumour development is closely monitored through infrared emission from copolymer nanoparticles.
This month's International Year of Light article reviews relevant advances and applications of plasmonic nanoparticles, from energy to health.